Advertisement
ZEG.DE Forex-Nachrichten
AstraZeneca Q2 Pre-tax Profit Down, But EPS Rise; Backs Positive FY26 View
British drug major AstraZeneca PLC reported Monday lower pre-tax pofit in its second quarter mainly on lower tax expenses, while earnings per share grew from last year with higher revenues, excluding weak China results. Further, the firm confirmed fiscal 2026 outlook for core earnings and revenue growth.
RTTNews
|
vor 46 Tagen
